Table 2.
Assessment of menopausal and urinary symptoms by studies included in the systematic review
Authors | Assessment of Menopausal Symptoms |
Assessment of Urinary Symptoms | Prevalence/Severity of Urinary Symptoms |
---|---|---|---|
Alfano et al., 200642 |
16 items from BCPT Symptom Checklist |
In past year, difficulty with bladder control when laughing or crying and difficulty with bladder control at other times; bother: 0 = not at all to 4 = extremely |
Difficulty with bladder control when laughing or crying = 46% (mean severity = 1.8 (0.9)); difficulty with bladder control at other times = 58.2% (mean severity = 1.8 (1.0)) |
Avis et al., 200436 |
15 items from BCPT Symptom Checklist |
In past 4 weeks, how bothered have you been by difficulty with bladder control when laughing or crying / at other times (1 = not at all to 5 = very much) |
Bladder control - laughing: not at all 74.8%, a little 9.9%, somewhat 8.9%, quite a bit 4.0%, very much 2.5%; bladder control - other: not at all 73.9%, a little 14.3%, somewhat 6.4%, quite a bit 3.5%, very much 2.0%; difficulty with bladder control reported as bothersome by less than 30% |
Avis et al., 200540 |
15 items from BCPT Symptom Checklist |
In past 4 weeks, how bothered have you been by difficulty with bladder control when laughing or crying / at other times (1 = not at all to 5 = very much) |
Difficulty with bladder control (age categories): 25-34 (n=25), 16%; 35-39 (n=41), 22.0%; 40-44 (n=54), 30.2%; 45-50 (n=82), 51.2%; Total N = 202, 35.3%; p = .0007 - problems increased with age |
Chin et al., 200946 |
FACT-ES | In past 7 days, 4 questions about urinary tract symptoms since endocrine therapy; asked to indicate how true a statement was for them: 0 = not at all to 4 = very much |
Dysuria, none = 87%, mild (1/2) = 10%, moderate/severe (3/4) = 2%; urinary incontinence, none = 63%, mild (1/2) = 30%, moderate/severe (3/4) = 3%; urinary urgency, none = 57%, mild (1/2) = 27%, moderate/severe (3/4) = 14%; increased urinary tract infections, none = 88%, mild (1/2) = 8%, moderate/severe (3/4) = 4% |
Couzi et al., 199531 |
Investigator-developed questionnaire |
In last 4 weeks, difficulty with bladder control |
Reported symptom 36% (n = 66 / 183) ; 55% of those reported symptom severity as mild, 22% as moderate, 23% as severe |
Ganz et al., 200032 |
7 items adapted from BCPT Symptom Checklist |
In past 4 weeks, how bothered have you been by difficulty with bladder control when laughing or crying / at other times (0 = not at all to 4 = extremely) |
Reported “stress urinary incontinence” at baseline = 51% ; 1 reported urinary incontinence only, 8 reported urinary incontinence and hot flashes, 27 reported urinary incontinence, hot flashes, and vaginal dryness; 1 reported urinary incontinence and vaginal dryness; at baseline urinary scale score for all women = 0.59 (0.82); effect of intervention on urinary incontinence not reported separately from menopausal symptoms |
Ganz et al., 200234 |
Items from BCPT Symptom Checklist |
In past 4 weeks, how bothered have you been by difficulty with bladder control when laughing or crying / at other times (0 = not at all to 4 = extremely) |
Frequency of bladder problems when laughing or crying (P = .003) and at other times (P = .007) increased significantly over time |
Ganz et al., 200335 |
42 items from BCPT Symptom Checklist |
In past 4 weeks, how bothered have you been by difficulty with bladder control when laughing or crying / at other times (0 = not at all to 4 = extremely) |
Approximations from graph: 25 - 34 years = 21%, 35 - 39 years = 20%, 40 - 44 years = 35%, 45 - 51 years = 38% |
Greendale et al., 200133 |
Items from BCPT Symptom Checklist |
In past 4 weeks, difficulty with bladder control when laughing or crying, difficulty with bladder control at other times; bother: 0 = not at all to 4 = extremely |
Urinary incontinence score mean = 14.8 (20.2), range = 0 to 100 |
Gupta et al., 200643 |
Menopausal Rating Scale with 2xyxweek recall | Urinary problems (difficulty urinating, increased need to urinate, bladder incontinence); severity: 0 = mild to 4 = severe |
Reported urinary problems = 55%; reported moderate to severe symptoms = 39% |
Land et al., 200437 |
17 items from existing instruments including the BCPT Symptom Checklist |
In past 7 days, bladder problems | CMF versus AC: ratio of the odds of reporting being at least’a little bit bothered by bladder problems = 4.2, 99.8 CI = 1.262, 13.767, p = .0002 |
Leining et al., 200644 |
16 items from BCPT Symptom Checklist |
In past 4 weeks, how bothered have you been by difficulty with bladder control when laughing or crying / at other times (0 = not at all to 4 = extremely) |
Reported loss of bladder control “slightly bothersome or more severe symptoms:” laughter 26%, other 25% |
Morales et al., 200438 |
Leuven Menopause Form | In past 7 days, did you have frequent urination (even at night) and urgency, urine loss when coughing, sneezing and laughing: not at all; yes, with minor inconvenience; yes, with moderate inconvenience; yes, with severe inconvenience; yes, intolerable |
Endocrine therapy naive patients (n = 144) prevalence of urinary problems at baseline = 28% (n = 41);urinary problems at baseline (n = 164): tamoxifen first line patients: mild to moderate = 23%; randomized trial of tamoxifen or letrozole patients: mild to moderate = 23%; NSAI first-line patients: mild to moderate = 39%; (N)SAI previous tamoxifen patients: mild to moderate = 25%; urinary problems at 1 month (n = 163): tamoxifen first line patients: mild to moderate = 35%; randomized trial of tamoxifen or letrozole patients: mild to moderate = 28%; NSAI first-line patients: mild to moderate = 43%; (N)SAI previous tamoxifen patients: mild to moderate = 37%; urinary problems at 3 months (n = 162): tamoxifen first line patients: mild to moderate = 36%; randomized trial of tamoxifen or letrozole patients: mild to moderate = 32%; NSAI first-line patients: mild to moderate = 35%; (N)SAI previous tamoxifen patients: mild to moderate = 15%* |
Oleske et al., 200439 |
Symptom Rating Scale (later modified for use in the National Surgical Adjuvant Breast and Bowel Project) |
In past 7 days, difficulty in bladder control |
Reported symptoms = 39%: mild 25%, moderate 16%, severe 4% |
Schover et al., 200645 |
7 items adapted from BCPT Symptom Checklist |
In past 4 weeks, how bothered have you been by difficulty with bladder control when laughing or crying / at other times (0 = not at all to 4 = extremely) |
Mean = .67 (1.2) at baseline |
Stanton et al., 200541 |
42 item from BCPT Symptom Checklist |
In past 4 weeks, difficulty with bladder control (when laughing or crying); difficulty with bladder control (at other times); presence / absence = 1/0; bother: 0 = not at all to 4 = extremely |
Sample 1: 0.52 (.47 to .58); Sample 2: 0.38 (.33 to .43); Sample 3: 0.32 (.28 to .38); Sample 4: 0.40 (.31 to .50) |
Data also presented for no symptoms and severe to intolerable symptoms
BCPT = Breast Cancer Prevention Trial Symptom Checklist from the National Surgical Adjuvant Breast and Bowel Project
QOL = quality of life
BCS = breast cancer survivors
BC indicates breast cancer
CMF chemotherapy regimen = cyclophosphamide, methotrexate, and 5-fluorouracil
AC chemotherapy regimen = doxorubicin and cyclophosphamide
CI = confidence interval
PCS = Physical Component Summary Score; MCS indicates Mental Component Summary Score
NSAI = non-steroidal aromatase inhibitors
(N)SAI = non-steroidal and steroidal aromatase inhibitors